As per a new study, it has been found that a specific Hepatitis B infection served to be a predictor for the future of pancreatic cancer by around 24 percent.
The researchers of the study analyzed the association that existed between the Hepatitis B infection “HepB” & pancreatic cancer. They even analyzed the independent mortality of the predictors.
The researchers concluded that this turns out to be the largest study towards revealing that Hepatitis B virus infection could increase the risk of developing pancreatic cancer by as much as 24 percent. There have been previous research items published in the years 2012 & 2015 that indicated that the HepB infection turned out to be the “causal agent” of enhancing the risks of developing pancreatic cancer.
The research team stated that the young patients (nearly 60 years old) having hepatitis B should be maintained under close observation by the clinicians –particularly the ones having the high risk for developing pancreatic cancer. This study throws light into the effectiveness of the Hepatitis B vaccination towards preventing pancreatic cancer. A vaccination for hepatitis B has been in existence since 1982. In the United States of America, 2 combination and 3 single-antigen vaccines for hepatitis B have been given license.
As there could be hope for preventing pancreatic cancer with the help of Hepatitis B vaccination, there could be some potential side effects to the same. Some of the combination Hepatitis B vaccines available out there include PEDIARIX (combination of Hepatitis B, tetanus, IPV –inactivated poliovirus, and DTaP –acellular pertussis) vaccines and TWINRIX (combination of Hepatitis B & Hepatitis A) vaccines.
Most of the pharmacies in the United States of America offer hepatitis vaccinations.